All posts by imreal

Registration Open for the 10th JADPRO Live, an Educational Conference for Oncology Advanced Practitioners


News Image

“This conference provides not only updates on cutting-edge therapies but also a chance to explore more nuanced topics such as specialty care of the adolescent and young adult and managing cancer pain during the opioid epidemic.”

JADPRO Live, the leading educational conference for oncology advanced practitioners (APs), returns in person this year to Aurora, Colorado, from October 20 through 23, 2022. With more than 1,500 attendees in 2019, including nurse practitioners, physician assistants, pharmacists, and advanced degree nurses, JADPRO Live has become the must-attend event of the year for oncology providers to interpret and apply best available evidence in oncology and hematology, exchange knowledge and clinical experiences, and improve care for their patients with cancer.

“As the challenges of caring for patients with cancer increase, the roles of the advanced practitioner have become even more important,” said Jennifer S. Webster, MN, MPH, RN, AOCNS, NPD-BC, of Georgia Cancer Specialists affiliated with Northside Hospital Cancer Institute and Conference Chair of JADPRO Live 2022. “This conference provides not only updates on cutting-edge therapies but also a chance to explore more nuanced topics such as specialty care of the adolescent and young adult and managing cancer pain during the opioid epidemic.”

The theme of this year’s meeting is “Reaching the Peak of Practice,” and reflects the value of APs practicing at the top of their license in order to meet growing patient care needs. This conference marks the tenth JADPRO Live, which has grown exponentially since its inception.

Along with triple-certified educational sessions, there will be ample networking opportunities at peer roundtables, industry resources in the Exhibit Hall, and a Poster Hall showcasing clinical posters, industry encore posters, and—new this year—patient perspective posters. On-demand sessions will be available shortly after the conference concludes and will be accessible until the end of the year.

JADPRO Live is inspired by the Journal of the Advanced Practitioner in Oncology (JADPRO), the first peer-reviewed journal written by and for oncology and hematology advanced practitioners. JADPRO Live is held in conjunction with the annual meeting of the Advanced Practitioner.

Society for Hematology and Oncology (APSHO), a society of more than 3,500 specialized clinicians who are on the front lines of caring for patients with cancer.

More information about the conference is available at http://jadprolive.com/.

About JADPRO Live

JADPRO Live is the premier conference for advanced practitioners in oncology, featuring education targeted toward higher-level thinking and practical application in the patient setting. This year’s meeting will run from October 20–23, 2022 in Aurora, Colorado

About APSHO

The [Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for nurse practitioners, physician assistants, pharmacists, and advanced degree nurses. The mission of APSHO is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology

About Harborside

Harborside is the foremost medical communications company that oncology clinicians turn to for accurate content, news, and education. The company is based in Huntington, New York, and is the publisher of the Journal of the Advanced Practitioner in Oncology(JADPRO), The ASCO Post, and JNCCN—Journal of the National Comprehensive Cancer Network. Harborside designs educational resources for nurse practitioners, physician assistants, pharmacists, and other advanced practitioners by publishing JADPRO, organizing the JADPRO Live conference, and providing the management services for the Advanced Practitioner Society for Hematology and Oncology (APSHO).

Share article on social media or email:

WellPower Partners with Natural Language Processing (NLP) Platform Augintel to Help Clinicians Save Time and Improve Clinical Outcomes


News Image

“With today’s overwhelming demand for behavioral health services, giving clinicians a complete understanding of the people they care for, while concurrently saving them time, should be a key goal for behavioral health organizations everywhere,” said Marty Elisco, CEO of Augintel.

Augintel, an NLP-based SaaS platform that gives clinicians a deeper understanding of the people they care for, today announced that WellPower, Denver’s community mental health provider, has selected the Augintel platform to read and process extensive amounts of case notes. The service is designed to help clinicians make well-informed decisions that will lead to improved clinical outcomes.

Like many behavioral health organizations, WellPower understands the value of the observations of clinicians and specialists, but was struggling to aggregate and comb through narrative data in an efficient way. They needed a streamlined method to access and assess that information to monitor for risk factors, quality of services being delivered, and fidelity to practice models. Recognized nationally for innovative and effective behavioral health care, WellPower looked for an innovative solution to better access notes and chose Augintel.

“Reducing burdens and burnout among our clinical staff is a top priority for us,” said Wes Williams, CIO of WellPower. “Partnering with Augintel will allow us to make significant progress toward this goal in a way that aligns with our commitment to dismantling institutional racism. We’re very aware of the potential of AI to perpetuate bias, and we wanted to make sure we were working with a different approach. NLP’s ability to reveal key indicators in narrative data will help our clinicians provide the most efficient and effective care possible, all while ensuring the proper controls are in place to counteract bias.”

“With today’s overwhelming demand for behavioral health services, giving clinicians a complete understanding of the people they care for, while concurrently saving them time, should be a key goal for behavioral health organizations everywhere,” said Marty Elisco, CEO of Augintel. “This goal can be achieved with an NLP platform that presents and provides key insights to clinicians so they can more quickly and confidently make the most impactful decisions. We look forward to collaborating with WellPower to empower their clinicians with the ability to do just this.”

WellPower also went the extra mile when it came to evaluating AI “trustworthiness” before moving forward with Augintel. To ensure that the tool as well as Augintel’s business practices were ethical and unbiased, Augintel was asked to take part in a “TRUST Assessment” with the Artificial Intelligence Institute at the Iliff School of Theology. As the acronym suggests, the TRUST Assessment ensures that AI-related processes are Transparent, Responsible, User-centered, Sustainable, and Team-centric. Ultimately, the TRUST evaluation process revealed to WellPower that Augintel has the proper business and technology practices in place to deliver tools that minimize bias.

About Augintel

Augintel is a health and human services-focused software development company focused on solving longstanding problems with data — specifically, narrative unstructured data. Augintel has pioneered the development of natural language processing (NLP) in social services to make narrative data accessible, searchable and actionable for staff across the organization – from front line clinicians to supervisors, quality managers and leaders.

About WellPower

We know the pursuit to live, feel and be well looks different for each person. At WellPower, we power the pursuit of well-being by supporting and promoting the vital connection between a person’s mental health and overall wellbeing. Our nationally-recognized services help children, families and adults in the Denver community create a path to living happier and healthier lives.

Share article on social media or email:

American Holistic Nurses Association Selects Pacific College of Health and Science For Excellence in Holistic Nursing Education Award


“Since our founding in 1986, Pacific College of Health and Science has been dedicated to top-tier, cutting-edge holistic nursing education.This award is proof that we are reaching a whole new generation of nurses with healing integrative modalities.”

Pacific College of Health and Science announced today it has earned the Excellence in Holistic Nursing Education Award from the American Holistic Nursing Association (AHNA). As a specialty nursing association serving more than 5,500 nurses and holistic healthcare professionals both nationally and internationally, AHNA’s mission is to illuminate holism in nursing practice, community, advocacy, research, and education. The organization’s vision is that every nurse is a holistic nurse, and Pacific College of Health and Science’s leadership in holistic nursing education is making that vision a reality.

“Since our founding in 1986, Pacific College of Health and Science has been dedicated to top-tier, cutting-edge holistic nursing education,” said Malcolm Youngren, President, and CEO of Pacific College of Health and Science. “This award is proof that we are reaching a whole new generation of nurses with healing integrative modalities. It is an honor to be recognized by the AHNA for this prestigious award.”

Applications for the Excellence in Holistic Nursing Education Award were reviewed by the Holistic Nurse of the Year Awards Committee, and the choices were finalized by the AHNA Board of Directors. Pacific College of Health and Science was officially recognized for this award at the AHNA Conference Awards Banquet on Friday, June 10th.

“Thank you for your dedication to your institution and to furthering holistic nursing practices,” said Terri Roberts, Executive Director of AHNA. “Congratulations on your award.”

Pacific College of Health and Science’s is teaching students to use evidence-based scientific and holistic knowledge as a foundation in healthcare. This innovative curriculum helps students deepen their understanding of cutting-edge healing modalities giving them the ability to thrive in existing or emerging traditional, integrative and holistic healthcare settings. Through this unique positioning, Pacific College of Health and Science assists future healthcare professionals in leading the holistic healthcare movement.

Students wishing to enroll or learn more about Pacific College of Health and Science’s nursing program, including prerequisites, admissions requirements, schedule, course descriptions, tuition & fees, and financial aid information, can visit https://www.pacificcollege.edu/nursing

###

About Pacific College of Health and Science:

Pacific College of Health and Science was founded in 1986 in San Diego to offer licensure-qualifying programs in Chinese medicine and massage therapy. The college subsequently established branches in New York and Chicago. It holds regional accreditation with the WASC Senior College and University Commission (WSCUC), as well as Chinese medicine and nursing programmatic accreditation. Over the years, it has expanded its programs to include three advanced programs in Holistic Nursing, a certificate in Medical Cannabis, a Master of Science in Health and Human Performance and a Bachelor of Science in Public Health Education and Promotion. Pacific College is home to a faculty of over 200 professors at the forefront of curriculum development. The college offers on-site education to 1,500 students and online training to another 800. More than 5,500 students have earned degrees at the college, with hundreds more earning certificates.

Share article on social media or email:

Prominent NYC Orthopedic and Sports Medicine Specialist, Jonathan L. Glashow M.D. has been Selected for Inclusion on the New York Super Doctors ® 2022 List


News Image

“It is such an honor to receive this distinguished award from Super Doctors,” says Dr. Glashow.

Dr. Jonathan Glashow is a top sports medicine specialist and arthroscopic/orthopedic surgeon, specializing in complex sports injuries such as ACL, Rotator cuff, labrum, and biceps among others. In addition, cutting-edge cement-less robotic knee replacement. As a result of his success, Dr. Glashow has been selected by Super Doctors® as one of the top doctors in New York for 2022. This award is given to the area’s best doctors in various medical specialties. The list of distinguished physicians will be published in The New York Times Magazine and online at http://www.superdoctors.com. Selection for Super Doctors is a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Each year, MSP Communications undertakes a rigorous multi-phase selection process that includes a survey of doctors, an independent evaluation of candidates by the research staff, a peer review by practice area and a good-standing and disciplinary check. Nationwide, Super Doctors represents an exclusive and diverse group of doctors who demonstrate outstanding skill and attention to exceptional patient care. With years of experience working with professional NBA, NHL, Premier League, NFL sports teams and their players, as well as patients from all over the world, Dr. Glashow is one of the best orthopedic surgeons in the country. He focuses on providing superior medical care for elbow, knee and shoulder injuries and conditions, as well as restorative treatments for degenerative diseases. He offers advanced arthroscopic and minimally invasive open surgical procedures to treat a number of joint-related conditions. Widely respected for his application of groundbreaking techniques, Dr. Glashow recently pioneered the first successful surgery using BEAR® implant technology commercially in October 2021.

“It is such an honor to receive this distinguished award from Super Doctors,” says Dr. Glashow.

More about Dr. Jonathan Glashow:

Jonathan Glashow M.D. earned his medical degree from Cornell University Medical College and completed his residency at Lenox Hill Hospital in New York City in orthopedic surgery. He earned subspecialty fellowship training in sports medicine and arthroscopic surgery at the Southern California Orthopedic Institute/UCLA in Los Angeles, California. Dr. Jonathan Glashow’s New York City orthopedic practice is located in Midtown Manhattan at 737 Park Avenue, Suite #1A. To find out more information about Dr. Jonathan Glashow or to schedule a consultation at his orthopedic practice in NYC, please call (212)794-5096 or visit

http://www.orthopedicsurgeonnyc.com.

Share article on social media or email:

Greenlight Guru Further Extends Commitment to Quality for Customers with Earning Both ISO 9001 and ISO 27001 Certifications


https://www.greenlight.guru/

This is our way of assuring customers we will always be capable of delivering secure, high-quality products and services that meet industry regulations and make it easier for them to do the same.

Greenlight Guru, pioneer of the world’s first MedTech Lifecycle Excellence Platform, announced today that it is now certified by the International Standards Organization for both ISO 9001 – Quality Management System Requirements and ISO 27001 – Information Security Management System Requirements.

These international standards outline the requirements an organization must comply with to demonstrate its processes are sound and effective. Greenlight Guru has met these requirements and achieved certification for both their own Quality Management System and data security processes, and is able to further meet the needs of their customers.

In order to receive such certifications, an organization must go through external audits with an independent, third-party agency to verify the required processes are in place and effective for both an effective Quality Management System (QMS) and Information Security Management System (ISMS).

“These ISO certifications are a huge testament to the next step of our ongoing commitment to quality,” said Mark Alpert, Director of Quality at Greenlight Guru. “This further proves to both our customers and the greater MedTech industry that we truly embody a quality culture here at Greenlight Guru and have the processes in place to monitor and ensure the effectiveness of our own operations moving forward.”

Using their own QMS software, Greenlight Guru was able to meet these process requirements and demonstrate their strategy of continuous improvement and accountability that inevitably improves the customer experience and bolsters their confidence in the organization.

“This is a major accomplishment for our team and I am elated to see their hard work recognized in these certifications,” added David DeRam, CEO of Greenlight Guru. “This is our way of assuring customers we will always be capable of delivering secure, high-quality products and services that meet industry regulations and make it easier for them to do the same.”

This announcement follows the unveiling of Greenlight Guru’s end-to-end MedTech Lifecycle Excellence Platform. The first-of-its-kind platform integrates cross-functional teams, processes, and data throughout the product lifecycle, giving visibility and traceability beyond compliance requirements to proactively overcome execution gaps and accelerate success.

###

About Greenlight Guru

Greenlight Guru is the only MedTech Lifecycle Excellence (MLE) platform purpose-built to give medical technology companies an end-to-end software solution to bring life-changing products to people. The platform integrates cross-functional teams, processes, and data throughout the product lifecycle, giving visibility and traceability beyond compliance requirements to proactively overcome execution gaps and achieve excellence. Hundreds of MedTech companies leverage the Greenlight Guru platform to bring high-quality devices to market globally while optimizing resources and mitigating risk. For more information about Greenlight Guru, visit http://www.greenlight.guru.

Media Contact

Naomi Gollmer

naomi.gollmer@greenlight.guru

(419) 518-0067

Share article on social media or email:

ContourMD Welcomes Dr. Stanley A. Okoro as Medical Director


Dr. Stanley Okoro is ContourMD's New Medical Director

Dr. Stanley Okoro is ContourMD’s New Medical Director

“I am very excited to be part of advancing the body contouring garments, especially postoperative garments with the goal to continue to explore ways to improve clinical outcomes,” said Dr. Stanley Okoro.

ContourMD Welcomes Dr. Stanley A. Okoro as Medical Director

ContourMD is proud to announce that they have officially partnered with Dr. Stanley Okoro of Georgia Plastic & Reconstructive Surgery and named him their new Medical Director. As ContourMD’s Medical Director, Dr. Okoro will review ContourMD’s compression garments and provide insights and feedback from a medical professional’s perspective and expertise.

“I am very excited to be part of advancing the body contouring garments, especially postoperative garments with the goal to continue to explore ways to improve clinical outcomes,” said Dr. Stanley Okoro.

About Dr. Stanley Okoro

Internationally renowned Plastic Surgeon Dr. Stanley Okoro is a double board-certified plastic surgeon. Known locally as “The Bow Tie Doctor,” he offers customized cosmetic plastic surgical procedures at his private practice location in metro Atlanta, Georgia & at his international practice locations, Lagos and Abuja, Nigeria. Dr. Okoro is a trusted name in the field of cosmetic plastic surgery and Medical Spa. His extensive experience in body contouring compression garments & design can be traced to his passion and experience in cosmetic & reconstructive surgery of the breast, body, and face.

About ContourMD

ContourMD is the leading and premier source for compression garments. Our surgical garments are trusted by numerous surgeons, physicians, medical professionals, and patients across the country. We are highly known for exceeding expectations and understanding compression technology and the recovery process. The compression garments at ContourMD are hand-stitched at our warehouse in Lenexa, KS, to fit every defined curve and subtle contour of the body.

Share article on social media or email:

SCALE Healthcare Announces Expansion Plans with the Addition of Six New Subsidiaries and the Launch of a New Online Healthcare Education Program


SCALE Healthcare

We’re seeing more of a need to help healthcare organizations and their physicians prepare for rapid and sustainable growth and we have a unique breadth of multidisciplinary services and knowledge to do so. ~Roy Bejarano, Co-Founder & CEO, SCALE Healthcare

SCALE Healthcare, the nation’s premier healthcare management consulting firm, today announced the addition of six new subsidiaries and the launch of a new online healthcare educational content platform, SCALE Education, that will elevate healthcare operations performance, leadership, and culture by offering insights from the nation’s top healthcare CEOs, expert market research analysis, and opportunities for peer engagement & collaboration.

Since the firm’s inception in 2019, SCALE Healthcare has quickly grown to employ +120 healthcare advisors plus operators in +10 cities across the US, expanded its offerings to include a full suite of multidisciplinary solutions, & grown to include 12 distinct but also highly synergistic subsidiaries.

SCALE Healthcare’s newest lineup of subsidiaries consist of:

1. SCALE Education

2. SCALE Market Research

3. SCALE Data Analytics

4. SCALE Compliance & Risk Management

5. SCALE ASCs

6. Due Diligence

7. MSO Formation

SCALE Education, the firm’s new online healthcare education platform, is a fee-based service that aims to further educate and modernize an outdated healthcare operations performance system, keep health leaders and physicians up to date with the latest thought leadership perspectives, provide cultural insights from healthcare CEOs, house expert market research analysis, and provide an engaging, interactive platform for peers to collaborate. SCALE Education will offer subscribers access to the latest healthcare insights from the top health CEOs in the world through its monthly “Leadership Series,” market research insights from leading healthcare data scientists, annual industry predictions from top industry leaders, proprietary research from SCALE’s top thought leadership content, and data reports that dig deep into challenges the healthcare industry faces, and more.

“The Private Equity industry has continued to invest heavily in healthcare service companies during and post the pandemic. As a result, there is growing demand for healthcare management consultants who have first-hand business knowledge,” said Roy Bejarano, Co-Founder and CEO, SCALE Healthcare. “We’re seeing more of a need to help these healthcare organizations and their physicians prepare for rapid and sustainable growth and we have a unique breadth of multidisciplinary services and knowledge to do so.”

SCALE Healthcare’s team of healthcare management consultants and its industry partners are a collection of well-known executives with real-world business experience in the healthcare industry. The firm provides relevant experience across every management discipline and clinical specialty that falls within healthcare services.

“SCALE’s multidisciplinary approach is a one-stop shop for healthcare companies looking to rapidly scale,” said Jason Schifman, Co-Founder and President, SCALE Healthcare. “We provide a broad range of solutions because we believe that narrow solutions can’t solve for today’s multi-disciplinary challenges that are facing our healthcare leaders during this dynamic period of change.”

“We not only offer solutions on how to scale healthcare businesses, but we also offer the reasons behind these recommendations. We are proud to be true business partners to our physician leaders, with their unique goals always top of mind. This is our differentiator, and it’s why we believe we’ve grown so rapidly in just three years – it’s very telling of where the healthcare industry is at now,” stated Mr. Bejarano. “We, too, look forward to scaling with our clients and physician partners as the industry evolves.”

To subscribe to SCALE Education, click here.

About SCALE Healthcare

SCALE Healthcare, founded in 2019, is the only healthcare management consulting firm in the US to offer a full range of multidisciplinary solutions exclusively to healthcare service organizations including provider platforms, hospital systems, and healthcare focused private equity groups. At SCALE Healthcare, our team of 100+ operational experts closely advise the nation’s top healthcare CEOs, executives, management teams, physician leaders and their organizations to accelerate growth & elevate management performance across healthcare services. We provide relevant, proven experience across every management discipline and clinical specialty that falls within healthcare services. Our team of advisors bring extensive healthcare knowledge in a broad range of specialty practice areas, providing our client partners with comprehensive, best-in-class insight and recommendations.

SCALE Healthcare’s lineup of companies includes:

1. SCALE Education

2. SCALE Marketing

3. SCALE Revenue Cycle Management (RCM)

4. SCALE Finance

5. SCALE Talent Search

6. SCALE Compliance & Risk Management

7. SCALE Corporate Development

8. SCALE ASCs

9. SCALE Consulting

10. SCALE Data Analytics

11. SCALE Market Research

12. SCALE Due Diligence

SCALE Healthcare is headquartered in New York City, with local market presence in California, Colorado, Connecticut, Illinois, Michigan, New Jersey, North Carolina, Pennsylvania, South Carolina, and Texas. For more information, visit http://www.scale-healthcare.com and follow us on LinkedIn.

Share article on social media or email:

Glaxon™ SuperGreens Immune introduces a more comprehensive formula with IMMUSE™ from Kyowa Hakko


GLAXON SUPER GREENS IMMUNE

“Everyone is looking to enhance their immune system these days, and the science supporting IMMUSE™ was a key factor in determining the formulation for this new product introduction.”

Glaxon™, producer of sports nutrition dietary supplements, has just released a new product in the greens supplement category. SuperGreens Enhanced Immune Edition combines the power of several Glaxon™ patented blends: Green Balance™, Supershrooms® Organic Mushroom Blend, and Betta Berries™ plus IMMUSE™, a postbiotic that provides immune support at a cellular level.

Joey Savage, the visionary and formulator of SuperGreens Enhanced Immune Edition, says, “Everyone is looking to enhance their immune system these days, and the science supporting IMMUSE™ was a key factor in determining the formulation for this new product introduction.”

IMMUSE™ is a branded form of the LC-Plasma strain of lactic acid bacteria with the ability to activate plasmacytoid dendritic cells (pDCs). Once triggered, these unique and rare immune cells circulate throughout the body mobilizing NK Cells, killer T cells, helper T cells, and B Cells for broad-range immune support. The lactic acid bacteria developed by Kirin Holding Company Limited and offered by Kyowa Hakko USA, IMMUSE™ is a thoroughly researched immune activator, with 29 published studies and over ten years of research supporting its mode of action.

SuperGreens Enhanced Immune Edition is also loaded with antioxidants, superfoods, fiber, and enzymes. The Supershrooms® Organic Mushroom Blend is designed to enhance mental focus, support athletic performance, and provide beta-glucans to help with healthy white blood cells.*

“We are excited to be in the greens category with IMMUSE™ featured as a key component of the Glaxon™ SuperGreens Enhanced Immune Edition formulation. With the global superfood powders market expected to hit USD 11.50 billion by 2030, there’s huge potential for innovative new product introductions,” said Karen Todd, MBA, RD, Vice President Global Brand Marketing, Kyowa Hakko USA, Inc.

SuperGreens Enhanced Immune Edition is currently a limited-edition item and comes in a Blueberry Açaí flavor. It can be purchased via Glaxon™ or GNC. To learn more about IMMUSE™, go to https://immusehealth.com/.

*The Food and Drug Administration has not evaluated these statements. This product is not intended to diagnose, treat, cure or prevent any disease.

About IMMUSE:

*IMMUSE™ is a clinically researched lactic acid bacteria developed by Kirin Holdings Co., Ltd. IMMUSE™ is a postbiotic that delivers a new, breakthrough approach to broad range immune support*. As a clinically researched immune activator* supported by 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells)*. The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko’s parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse® Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.

About GLAXON™:

GLAXON™ is a brand of mold breaking dietary supplements with an emphasis on cross category lifestyle solutions beyond just the active nutrition space. GLAXON™ is one of the fastest growing brands in the space that has become an emerging leader in market innovation. Leveraging growth by disruptive thought-provoking branding, product education, and transparent supplements that provide lifestyle solutions. GLAXON™ is headquartered in a 100,000 sq ft facility of product incubation including: design, formulation, manufacturing, marketing, and sales. GLAXON™ headquarters is uniquely built to fast-track product concepts from R&D to fully finished products all under one roof remaining true to the company mantra, “Made with Real Science”. GLAXON™ can be found at GNC, GLAXON.com, and select retailers globally. For more information visit GLAXON.com or find us on Instagram and TikTok.

Share article on social media or email:

HearingLife Encourages Hearing Health with New “Love Your Ears” Campaign


News Image

“Loving your ears means you take care of them and one of the best ways to do so is by having your hearing evaluated annually when you turn 60.”

HearingLife, a leader in delivering life-changing, personalized hearing care, announces the launch of “Love Your Ears,” a new campaign designed to break down stigmas around hearing loss and educate consumers on ways to care for and enhance their hearing.

“Far too many people have difficulty accepting hearing loss, feeling ashamed that they no longer hear the world around them like they used to,” says Dr. Leslie Soiles, Chief Audiologist with HearingLife. “Through our Love Your Ears campaign, we want to turn those thoughts into positive ones – that hearing loss is a testament to living a full and interesting life – and that everyone should have the opportunity to love what you hear every day.”

The campaign was developed in response to insights gained from a global YouGov survey* in late 2021; the results of which demonstrated that hearing is not prioritized proactively among other health conditions. According to the survey, while 1 in 3 people will plan a vision test in 2022, just 1 in 10 intend on scheduling a hearing test.

The global survey of more than 24,000 reveals that hearing well positively impacts relationships; those who use a hearing aid are three times more likely to be happier than those without. Since treating their hearing loss, 40 percent of hearing aid wearers report having better conversations, a third feel more connected to their family and 25 percent say there is less stress on their relationship.

The campaign is live now on the HearingLife website and on TV in select markets, plus exposure includes direct mail, email, newspaper, and social media content on all HearingLife channels. Campaign communications focus on the intense emotions that hearing enables from dinner parties to a baby’s cry, to everyday conversations with family and friends. The campaign emphasizes the importance of getting your hearing tested, and if you experience hearing loss, there are resources, including personalized hearing care solutions that can help you effectively hear and communicate again.

Dr. Soiles adds, “Loving your ears means you take care of them and one of the best ways to do so is by having your hearing evaluated annually when you turn 60. If you experience any kind of hearing decline before 60, don’t hesitate to address it. The experts at HearingLife’s care centers can help diagnose the cause of hearing loss and offer the latest solutions to help you hear at your full potential.”

To learn more about the Love Your Ears campaign and to learn how you or a loved one can receive life-changing hearing care, please visit HearingLife.com.

About HearingLife

HearingLife is a national hearing care company and part of the Demant Group, a global leader in hearing healthcare built on a heritage of care, health, and innovation since 1904. HearingLife operates nearly 650 hearing care centers across 42 states. We follow a scientific, results-oriented approach to hearing healthcare that is provided by highly skilled and caring professionals. Our vision is to help more people hear better through life-changing hearing health delivered by the best personalized care. To learn more, visit: https://www.hearinglife.com.

This study is conducted by YouGov on behalf of Audika Group and is based on a quantitative online survey (CAWI, Computer Assisted Web Interviews) among a total of 24,035 YouGov panelists in 14 countries. The survey was fielded throughout the month of December 2021 and includes a total of 18,451 interviews among people aged 18+, presenting a nationally representative sample based on age, gender, and geography. In addition, a boost of 5,584 interviews was conducted among people aged 50+ having hearing difficulties.

Share article on social media or email:

nView to Showcase Clinical Workflow Engine Solution at APA 2022


nView invites all APA 2022 attendees to come to Booth 1121 and see how nView helps providers efficiently and accurately assess, diagnose and monitor mental illness.

“APA 2022 provides us with a terrific opportunity to demonstrate to attendees how our new solution helps providers get the right answers at the right time to enable the right mental health outcomes and why we believe ‘healthy minds start with nView.'” – John Letter, nView CEO

nView Health, developer of the premier evidence-based behavioral health solution that combines gold-standard measurements on a single, modern platform, invites attendees of APA 2022, the annual meeting of the American Psychological Association (APA), to visit with nView at Booth 1121. There they can see how nView’s newest solution introduces an innovative approach to mental healthcare with digital workflows based that produce actionable data.

The intelligent workflow engine captures and shares data at every step of the behavioral healthcare process, providing insight to help providers assess and diagnose mental illness and determine the next steps to take in a patient’s care based on the conditions for which the patient meets criteria. This leads to a significant result: better outcomes for patients who suffer from mental illness.

The nView solution supports every stage of the clinical process:


  • Workflow technology — Use one tool to assess multiple conditions. Electronic behavioral health assessments and treatment processes are configurable within existing workflows to help accurately and efficiently screen, diagnose, treat and monitor patients.
  • Gold-standard measures — Validated tools inspire confidence in the delivery of timely, appropriate care. nView is the exclusive licensee of many of the world’s leading digital behavioral health scales and measurements used in clinical and academic research for more than 25 years.
  • Decision support — Evidence-based workflow technology uses algorithms to deliver data when needed to make informed decisions.
  • Clinical outcomes — With verifiable data, more easily provide the right follow-up care, including patient handoffs, coordination of services and measurement-based care.

“At nView, we are helping practitioners, researchers, educators and applied psychologists better assess, treat and deliver outcomes for their patients with mental illness,” said nView CEO John Letter. “APA 2022 provides us with a terrific opportunity to demonstrate to attendees how our new solution helps providers get the right answers at the right time to enable the right mental health outcomes and why we believe ‘healthy minds start with nView.'”

To arrange an in-person demo or meeting with an nView representative at APA 2022, please contact us.

ABOUT NVIEW HEALTH

nView Health is the premier provider of evidence-based software and supporting solutions used by research organizations and healthcare professionals around the world to help them identify, treat and monitor mental health disorders — a critical requirement for measurement-based care. nView is the exclusive licensee worldwide for a broad array of behavioral health screening solutions, structured interviews, and post-diagnosis severity measurement scales to monitor patient outcomes. To learn more, visit nview.com or follow nView Health on LinkedIn or Twitter.

Share article on social media or email: